|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| G01G 19/414 | (2006.01) | ||
| G09B 5/06 | (2006.01) | ||
| G09B 19/00 | (2006.01) | ||
| G16H 20/10 | (2018.01) |
| (11) | Number of the document | 4104824 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22170364.8 |
| Date of filing the European patent application | 2013-06-05 | |
| (97) | Date of publication of the European application | 2022-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2025-05-21 |
| (46) | Date of publication of the claims translation | 2025-08-25 |
| (30) | Number | Date | Country code |
| 201261656451 P | 2012-06-06 | US |
| (72) |
KLASSEN, Preston , US
TAYLOR, Kristin , US
|
| (73) |
Nalpropion Pharmaceuticals LLC ,
155 Franklin Rd, Suite 450, Brentwood, TN 37027,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos, skirtos panaudoti taikant pacientams su didele širdies ir kraujagyslių ligos rizika antsvorio ir nutukimo gydymo būdą |
| COMPOSITION FOR USE IN A METHOD OF TREATING OVERWEIGHT AND OBESITY IN PATIENTS WITH HIGH CARDIOVASCULAR RISK |
| Payment date | Validity (years) | Amount | |
| 2025-08-08 | 13 | 433.50 EUR |
| 2026-06-05 |